Literature DB >> 17431233

Cytochrome P450 genotyping and antidepressants.

Roy H Perlis.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17431233      PMCID： PMC1852041          DOI： 10.1136/bmj.39169.547512.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients.

Authors:  J Lundmark; F Bengtsson; C Nordin; M Reis; J Wålinder
Journal:  Acta Psychiatr Scand       Date:  2000-05       Impact factor: 6.392

Review 2.  Biological predictors of treatment response in affective illness.

Authors:  Roy H Perlis; Dan V Iosifescu; Perry F Renshaw
Journal:  Psychiatr Clin North Am       Date:  2003-06

3.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring study.

Authors:  Margareta Reis; Jiri Prochazka; Ad Sitsen; Johan Ahlner; Finn Bengtsson
Journal:  Ther Drug Monit       Date:  2005-08       Impact factor: 3.681

Review 5.  How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test.

Authors:  A A Nierenberg; A R Feinstein
Journal:  JAMA       Date:  1988-03-18       Impact factor: 56.272

6.  Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.

Authors:  G E Simon; J H Heiligenstein; L Grothaus; W Katon; D Revicki
Journal:  J Clin Psychiatry       Date:  1998-02       Impact factor: 4.384

7.  Does pretreatment insomnia or anxiety predict acute response to bupropion SR?

Authors:  A John Rush; Thomas J Carmody; Barbara R Haight; Carol B Rockett; Sidney Zisook
Journal:  Ann Clin Psychiatry       Date:  2005 Jan-Mar       Impact factor: 1.567

Review 8.  Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).

Authors:  David B Matchar; Mugdha E Thakur; Iris Grossman; Douglas C McCrory; Lori A Orlando; David C Steffens; David B Goldstein; Kathryn E Cline; Rebecca N Gray
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2007-01

9.  Pharmacogenetics of antidepressant medication intolerance.

Authors:  Greer M Murphy; Charlotte Kremer; Heidi E Rodrigues; Alan F Schatzberg
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

10.  The role of the primary care physician in patients' adherence to antidepressant therapy.

Authors:  E H Lin; M Von Korff; W Katon; T Bush; G E Simon; E Walker; P Robinson
Journal:  Med Care       Date:  1995-01       Impact factor: 2.983
  10 in total
  6 in total

1.  The bridging function of clinical pharmacology.

Authors:  Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-09       Impact factor: 2.953

Review 2.  Translating biomarkers to clinical practice.

Authors:  R H Perlis
Journal:  Mol Psychiatry       Date:  2011-06-28       Impact factor: 15.992

Review 3.  Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Bernhard T Baune
Journal:  EPMA J       Date:  2017-09-05       Impact factor: 6.543

Review 4.  Personalized medicine for depression: can we match patients with treatments?

Authors:  Gregory E Simon; Roy H Perlis
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

5.  A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.

Authors:  Changsu Han; Sheng-Min Wang; Won-Myong Bahk; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Laura Mandelli; Chi-Un Pae; Alessandro Serretti
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-11-30       Impact factor: 2.582

6.  When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D study.

Authors:  Roy H Perlis; Amanda Patrick; Jordan W Smoller; Philip S Wang
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.